Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations
Peter C Taylor,
Daniel Prieto-Alhambra,
Sarah Berry,
Ailsa Bosworth,
Clare Jacklin,
Kayoko Kaneko,
Sally Dickinson,
Helen McAteer
Affiliations
Peter C Taylor
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK
Daniel Prieto-Alhambra
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Sarah Berry
Crohn’s & Colitis, Hatfield, UK
Ailsa Bosworth
National Rheumatoid Arthritis Society (NRAS), Maidenhead, UK
Clare Jacklin
National Rheumatoid Arthritis Society (NRAS), Maidenhead, UK
Kayoko Kaneko
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK
Sally Dickinson
National Axial Spondyloarthritis Society, London, UK
